DrugPatentWatch Database Preview

Drugs in Development Information for Penclomedine

« Back to Dashboard

Summary for Penclomedine

US Patents	58
International Patents	504
US Patent Applications	93
WIPO Patent Applications	79
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2013-09-01)
Vendors	8

US Patents for Penclomedine

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Penclomedine		Methods and compositions for the treatment of a host with a cellular proliferative disease	Matrix Pharmaceutical, Inc. (Menlo Park, CA)
Penclomedine		Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof	Pharmacia & UpJohn AB (Stockholm, SE)
Penclomedine		Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof	Pharmaciaand Upjohn AB (Stockholm, SE)
Penclomedine		Self-emulsifiable formulation producing an oil-in-water emulsion	Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL)
Penclomedine		Particles with modified physicochemical properties, their preparation and uses	Knoll Aktiengesellschaft (Ludwigshafen, DE)
Penclomedine		Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof	Kabi Pharmacia AB (SE)
Penclomedine		Compound, composition and method for treating cancer

International Patents for Penclomedine

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Penclomedine	Austria	220894	2013-12-29
Penclomedine	Australia	1438695	2013-12-29
Penclomedine	Australia	681231	2013-12-29
Penclomedine	Canada	2180260	2013-12-29
Penclomedine	Germany	69431071	2013-12-29
Penclomedine	European Patent Office	0739210	2013-12-29
Penclomedine	Japan	H09507233	2013-12-29